|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5666 USD | +0.21% |
|
+1.83% | -2.33% |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Dec. 17 | VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 18.86M | - | - | - | ||
| 49.27B | |||||
| 44.15B | |||||
| 34.86B | - | ||||
| 27.38B | - | ||||
| 21.21B |
Select your edition
All financial news and data tailored to specific country editions
